Status:
COMPLETED
Aptus at Home: Co-design of a Home-based Monitoring System for Anaemia
Lead Sponsor:
Entia Ltd
Conditions:
Anemia
Iron Deficiency Anemia
Eligibility:
All Genders
18+ years
Brief Summary
Co-design of a home-based anaemia monitoring system with participants who have previous diagnosis of anaemia.
Detailed Description
The device/ monitoring system being developed is called Aptus home. Aptus home measures the haemoglobin and haematocrit levels in blood from a single drop of blood. By measuring these blood parameters...
Eligibility Criteria
Inclusion
- Prior diagnosis of anaemia
- Commitment to perform finger pricking to use the device every two weeks and complete 2 monthly questionnaires
- Participant's willingness to participate in 1 to 1 interviews and, or focus groups
- Understands and has a good level of spoken and written English
Exclusion
- No prior diagnosis of anaemia
- Not committed to perform two weekly finger pricks to use device and complete 2 monthly questionnaires
- Unwilling to attend interviews and focus groups
- Doesn't have a good level of written and spoken English
Key Trial Info
Start Date :
April 13 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 15 2021
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT03835364
Start Date
April 13 2018
End Date
January 15 2021
Last Update
February 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Entia Ltd, Room G11, Screenworks, Highbury Grove, Highbury and Islington
London, United Kingdom, N5 2EF